A new study published in CANCER reveals that younger women diagnosed with breast cancer often face delays in treatment. The research highlights that women aged 40 or younger are more likely to experience delays at multiple stages of care, with lower-income individuals particularly affected. These findings are key because breast cancer in younger women is often diagnosed at a later stage and tends to have more aggressive features compared to older women.
Delays in Diagnosis and Treatment
The study, conducted at 13 academic and community sites in the U.S. and Canada between 2006 and 2016, analyzed 1,071 women diagnosed with stage 0 to IV breast cancer at or before age 40. Researchers identified three types of delays: presentation delays (at least 90 days between noticing symptoms and seeing a healthcare provider), diagnostic delays (at least 90 days from the first visit to diagnosis), and treatment delays (at least 60 days between diagnosis and starting treatment). Among the participants, 153 experienced presentation delays, 120 faced diagnostic delays, and 228 had treatment delays. Women with annual household incomes below $50,000 were more likely to delay seeking care, despite 85% having insurance.
Income and Age as Key Factors
Income played a significant role in delays, even among insured women. The study notes that financial barriers can still hinder access to care, even in a relatively well-insured population. Younger women, particularly those in their 20s and 30s, were more likely to experience diagnostic delays once they entered the healthcare system.
This could be due to lower awareness of breast cancer risk in younger adults, misattributing symptoms to other causes, or clinicians being less likely to suspect cancer in this age group. Additionally, tumor biology influenced delays, with women having triple-negative breast cancer experiencing fewer diagnostic delays, possibly due to the aggressive nature of these tumors making them easier to detect. The authors emphasized that even within a well-insured cohort, financial constraints significantly impact access to timely care.
Implications for Early Detection
While delays were not directly linked to survival outcomes, they were associated with later-stage diagnoses, especially in women with HER2-positive luminal B tumors. This highlights the need for increased awareness among both patients and providers about the possibility of breast cancer in younger women, who typically fall outside routine screening guidelines. The study’s findings show the importance of timely evaluation of suspicious breast changes in younger women, even in the absence of routine screening. By addressing delays at various stages of care, healthcare systems can improve outcomes for this vulnerable population. The researchers also noted a “survival paradox,” where aggressive cancers, despite being diagnosed and treated more quickly, still have poorer outcomes due to their inherent biological aggressiveness.
